SAN DIEGO, Oct. 20, 2017 (GLOBE NEWSWIRE)

Organovo today presented new preclinical data showing extended survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into diseased animal models. This data will be presented at The Liver Meeting 2017 (American Association For The Study of Liver Diseases or “AASLD”) by Vaidehi Joshi, Scientist I, Therapeutics, at Organovo.

Organovo previously implanted its 3D bioprinted human liver tissue patches onto the livers of healthy NOD/SCID mice, and is now presenting additional data from promising early studies in an established model for alpha-one-antitrypsin deficiency (“A1AT”). The tissue was composed of human hepatocytes and select non-parenchymal cells. Serum and histopathologic evaluation of the implanted therapeutic tissue showed engraftment, retention and a high degree of disease clearing through 125 days post-implantation, a significant increase in duration from the Company’s first preclinical studies, which demonstrated functionality through 28 days. These results demonstrate a significant increase in the reported duration of implanted human hepatocyte synthetic function, demonstrating sustained presence of key human liver proteins such as albumin and A1AT in the animal bloodstream. Importantly, pathologic evaluation of diseased animals receiving implanted bioprinted liver tissues suggests an approximately 75 percent reduction in the pathologic hallmarks of the disease in treated animals versus non-treated control animals in the region of implant.

“With tens of thousands of patients being treated for inborn errors of metabolism (“IEMs”) in the U.S., and an annual cost per patient that exceeds $250,000 for drug therapy alone, Organovo continues to advance a novel therapeutic solution for direct surgical implantation,” said Eric David, M.D., J.D., chief strategy officer and executive vice president of preclinical development, Organovo. “Our preclinical data continues to show robust engraftment and durability of the liver tissue and strong early evidence of successfully impacting the disease state in animal models. Taken together, these data support continued preclinical development of Organovo’s 3D bioprinted liver tissue for therapeutic use.”

“The data show that the approach of delivering a 3D bioprinted tissue patch directly to the liver offers great promise in solving the engraftment and integration issues that have held back many cell and gene therapy attempts at these diseases,” said Dr. David Brenner, vice chancellor of Health Sciences and dean of the School of Medicine at UC San Diego, who is also an advisor to Organovo. “We’re encouraged by these solid early results, and are eager to see this work advance to the next stages. UC San Diego’s ability to leverage translational research to understand and redress disease progression is one of the many reasons we’re ideally suited for this kind of collaboration.”

Focusing first on pediatric inborn errors of metabolism, Organovo intends to submit an Investigational New Drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) for its therapeutic liver tissue in calendar-year 2020. In the next 12 months, the Company expects to optimize its final liver tissue design and continue pre-GLP studies, including efficacy, safety and dosing studies in small animal disease models for IEMs. Organovo is also seeking orphan designation in the U.S. and will partner with contract research organizations (“CROs”) to define and scope IND enabling studies. 

Source: Organovo

Illustration Photo: Bioprinted vascular conduit after 28 days of bioreactor conditioning, highlighting the layered architecture and deposition of extracellular matrix (blue color). Image is Masson’s Trichrome (20x). (Credit: Organovo)

Comments

No comments to display.

Related posts

EU's Call for Proposals: An empowering, inclusive Next Generation Internet

The objective is to support actions on smarter, open, trusted and personalised learning solutions to optimise digital learning and to allow learners to engage and interact with content and with peers.
Application Deadline in 5 months
17 minutes ago

Singapore to establish Additive Manufacturing Facility and Applications in Maritime Sector

The facility’s location also leverages PSA’s parts supplier base and facility operations to support just-in-time inventory. This move towards digitised inventories reduces the need to hold excess inventory, which lowers storage costs, while shortening turnaround time from weeks to days due to improved availability of spare parts. In the long run, PSA will expand the scope of these services to the wider maritime industry, including ship owners, to help build its business adjacencies.
23 minutes ago

EU's Call for Proposals: The AQUAEXCEL2020 twelfth call for access

The facilities available cover the entire range of production systems (cage, pond, recirculation, flowthrough, hatchery and disease challenge); environments (freshwater, marine, cold, temperate and warm water); scales (small, medium and industrial scale); fish species (salmonids, cold and warm water marine fish, freshwater fish and artemia); and fields of expertise (nutrition, physiology, health & welfare, genetics, engineering, monitoring & management technologies).
Application Deadline in a month
44 minutes ago

Environment and Big Data: Role in Smart Cities of India

This study identifies six environmental factors, which should be integrated in the development of smart cities. These environmental factors include indicators of landscape and geography, climate, atmospheric pollution, water resources, energy resources, and urban green space as a major component of the environment.

Corteva Agriscience and IRRI Ink Partnership to Develop Advanced Rice Technologies and Programs

The partnership seeks to improve the genetic outcomes of breeding programs, encourage sustainable rice cultivation, and develop new rice varieties which deliver higher yields and are more resilient against biotic and abiotic stresses.

Call for Applications: Communication projects which mitigate anthropogenic climate change

The Minor Foundation for Major Challenges (MFMC) is inviting applications from all over the world to fund communication projects which mitigate anthropogenic climate change.
Application Deadline in a month

EU's Call for Proposals: Digital technologies for improved performance in cognitive production plants

Proposals need to develop new technologies to realise cognitive production plants, with improved efficiency and sustainability, by use of smart and networked sensor technologies, intelligent handling and online evaluation of various forms of data streams as well as new methods for self-organizing processes and process chains.
Application Deadline in 4 months

Study reveals best use of wildflowers to benefit crops on farms

For the first time, a Cornell University study of strawberry crops on New York farms tested this theory and found that wildflower strips on farms added pollinators when the farm lay within a "Goldilocks zone," where 25 to 55 percent of the surrounding area contained natural lands.

EU's Call for Proposals: Reinforcing the EU agricultural knowledge base

Activities shall analyse and compare the approaches taken on their performance and impact for farmers/foresters as well as effectivity of the communication and information channels used for dissemination in countries and regions.
Application Deadline in 3 months

The Bali Fintech Agenda: A Blueprint for Successfully Harnessing Fintech’s Opportunities

In response to the Bali Fintech Agenda, the World Bank will focus on using fintech to deepen financial markets, enhance responsible access to financial services, and improve cross-border payments and remittance transfer systems.